People with hepatitis B who have cirrhosis should be prioritised for liver cancer screening
Even moderate drinking increases risk of advanced liver fibrosis for people with HIV and HCV co-infection
Sofosbuvir + ribavirin is safe and effective for HCV recurrence after liver transplantation
AbbVie 3-drug combination cures 92 to 96% of hepatitis C patients with cirrhosis
Sofosbuvir + simeprevir dual therapy shows high cure rates for hepatitis C patients with or without cirrhosis
Successful hepatitis C treatment reduces risk of liver cancer and death, but most remain untreated
Sofosbuvir taken before or after liver transplant reduces hepatitis C recurrence
Hepatitis B treatment with entecavir or tenofovir lowers, but does not eliminate, liver cancer risk
Liver fibrosis linked to immune activation in HIV/HCV co-infected women
